Literature DB >> 4370834

Acrodermatitis enteropathica. A clinical and biochemical survey.

K H Neldner, L Hagler, W R Wise, F B Stifel, E G Lufkin, R H Herman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4370834     DOI： 10.1001/archderm.110.5.711

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  7 in total

Review 1.  [Positive side-effects of antibiotic and antimicrobial drugs in therapy (author's transl)].

Authors:  L Illig
Journal:  Infection       Date:  1979       Impact factor: 3.553

2.  Immunological deficiency, cancer, and prostaglandins.

Authors:  D F Horrobin; R A Karmali; A I Ally; M S Manku; R O Morgan
Journal:  Br Med J       Date:  1977-10-22

3.  Acrodermatitis enteropathica.

Authors:  P J Aggett
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

4.  Serum and hair zinc as predictors of clinical symptoms in acrodermatitis enteropathica.

Authors:  P Anttila; O Simell; S Salmela; E Vuori
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

5.  Reversible intestinal mucosal abnormality in acrodermatitis enteropathica.

Authors:  R Kelly; G P Davidson; R R Townley; P E Campbell
Journal:  Arch Dis Child       Date:  1976-03       Impact factor: 3.791

6.  Fatty acid composition of plasma lipids in acrodermatitis enteropathica before and after zinc supplementation.

Authors:  B Koletzko; A Bretschneider; H J Bremer
Journal:  Eur J Pediatr       Date:  1985-03       Impact factor: 3.183

7.  Clioquinol synergistically augments rescue by zinc supplementation in a mouse model of acrodermatitis enteropathica.

Authors:  Jim Geiser; Robert C De Lisle; David Finkelstein; Paul A Adlard; Ashley I Bush; Glen K Andrews
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.